Overview (21 Sep 2026)
Auro Laboratories Ltd
AUROLAB
INE292C01011

Pharmaceuticals
0.2

Prev. Close
Previous Close
249.9
Current Close
250.1
Current High
258.7
Current Low
245.55
52 Week High
317
52 Week Low
159
Resistance 1
257.35
Resistance 2
264.60
Support 1
244.20
Support 2
231.05
Std Deviation
3.81%
DMA 200
255.98
DMA 50
241.96
DMA 20
245.55
Fundamentals and Ratios
Standalone
Trailing EPS
5.67
Forwad EPS
8.49
Trailing P/E
44.11
Forward P/E
29.45
PEG Ratio
1.16
Mkt. Cap (Cr)
Market Cap (Cr)
155.87
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue8.779.839.398.842.7730.74
Other Income0.110.660.180.980.422.01
Total Income8.8810.509.579.813.1932.75
Interest1.371.491.520.960.284.25
Expenditure-7.75-8.90-7.83-8.09-3.20-27.80
PBDT0.000.000.000.000.000.00
Depreciation-0.91-0.90-0.98-0.65-0.27-2.81
PBT1.131.461.741.720.004.81
Tax-0.09-0.490.21-1.000.00-1.28
Equity0.000.000.000.000.000.00
OPM12.9014.8018.5019.460.0015.00
Net Profit1.050.971.950.72-0.113.53
NPM11.939.8620.788.1-3.7911
EPS1.681.563.131.1505.67
Consolidated
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings